Executive Interview – Touchstone Innovations

Published on 5 January 2017

Touchstone Innovations (previously Imperial Innovations) is an investment company focused on building and creating companies.
In this webcast, CEO Russ Cummings discusses the significance of the recent rebranding and what it means for its broader investment strategy. He outlines the defining milestones in 2016 including the recently announced deal between PsiOxus and Bristol-Myers Squibb before finally giving an overview of what to expect from Touchstone Innovations in 2017.
Click below for associated interviews:

Crescendo Biologics Executive Interview
PsiOxus Therapeutics Executive Interview
MISSION Therapeutics Executive Interview
Featurespace Executive Interview

Share this with friends and colleagues